Clinical Study
Investigating γ H2AX as a Biomarker of Radiosensitivity Using Flow Cytometry Methods
Table 1
Clinical features of control and radiosensitive groups.
| Clinical group | Age at diagnosis (mean and range) | Preexisting cardiovascular disease/hypertension | Preexisting type II diabetes | Smoker/exsmoker | Mean follow-up time posttreatment (years) | Mean time to onset of Grade 3 proctitis (range) |
| Control | 69 (60–77) | 8/20 | 3/20 | 8/20 | 6 | N/A | Radiosensitive | 73 (68–76) | 6/10 | 1/10 | 4/10 | 7 | 21 months (9–41 months) |
|
|